South Korea Daily Briefing

Korean financial media's framing of today's market action is unambiguous: the Democratic congressional sweep triggered a 'Blue Tsunami' that swept through KOSPI's semiconductor sector. Samsung Electronics and SK Hynix — the two-top of KOSPI's weighting — led the decline as markets priced AI data-center capital expenditure restrictions under Democratic AI governance proposals. The practical concern is direct: Democratic AI regulation proposals have specifically targeted data-center energy consumption and capital-intensity, which would reduce HBM memory demand from hyperscaler customers. This is the first time political risk in Washington has transmitted this directly and this quickly into Korean semiconductor names, and the speed of the repricing (-9.4% in one session) suggests the consensus positioning was extremely concentrated.

Against the market carnage, KT&G (033780.KS) delivered a positive counter-narrative: Q3 revenue and operating profit at record levels, plus a four-year KRW 5 trillion shareholder return plan covering dividends and buybacks. For Korea's governance-discount bulls, KT&G's announcement is evidence that chaebol-adjacent corporate reform is real and spreading. The ₩5 trillion commitment is material relative to KT&G's market cap and signals a management team that understands capital allocation under FSC pressure. KT&G has been a beneficiary of FSC's enhanced shareholder return guidance; it is one of the clearest examples of the 'Korea discount' narrowing through execution rather than just regulatory mandate — and tomorrow's trading will likely see it outperform a market still processing semiconductor shock.

Korean brokerage data confirms foreign institutional selling concentrated in Samsung Electronics and SK Hynix while simultaneously accumulating bio (Samsung Biologics, domestic biotech), beauty (K-beauty names), and defense stocks. This rotation is significant: the semiconductor trade was the consensus Korea exposure for global EM allocators, and a forced unwind of that thesis — driven by US AI regulatory risk — creates a vacuum that the bio/beauty/defense basket is filling. Samsung BioLogics' partial strike (10% of workers, QC operations, 3-week duration beginning today) is the near-term operational risk that complicates the bio leg of that rotation trade — watch for any escalation or resolution in the first 48 hours.